Fotios Diamantogiannis is a senior executive specializing in market access and healthcare policy, with extensive experience across the pharmaceutical and healthcare sectors. His expertise includes health economics and outcomes research (HEOR), health technology assessment (HTA), pricing and reimbursement, and access to innovative therapies in Greece and Cyprus. He held increasingly senior market access positions at Bristol-Myers Squibb, covering oncology, immunology, and cardiovascular disease. 

He serves as a Board Member and Scientific Advisor of the Market Access Hellenic Society (EL.E.M.A.), and as a Cooperation Committee Member and Lecturer for the Diploma in Pharmaceutical Market Access, a specialized professional program offered by the Center of Continuing Education and Lifelong Learning (K.E.DI.VI.M.) at the University of Piraeus in collaboration with EL.E.M.A. 

He has co-authored HEOR studies presented at ISPOR European Congresses. His earlier leadership experience includes serving as Managing Director and Chair of the Board at a general hospital. He holds a Master’s degree in Industrial Location and Development from Vrije Universiteit Brussel and a Diploma in Chemical Engineering from the National Technical University of Athens.